Search Results - "Mohapatra, Bhopal C."

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Structural Determinants of the Gain-of-Function Phenotype of Human Leukemia-associated Mutant CBL Oncogene by Nadeau, Scott A., An, Wei, Mohapatra, Bhopal C., Mushtaq, Insha, Bielecki, Timothy A., Luan, Haitao, Zutshi, Neha, Ahmad, Gulzar, Storck, Matthew D., Sanada, Masashi, Ogawa, Seishi, Band, Vimla, Band, Hamid

    Published in The Journal of biological chemistry (03-03-2017)
    “…Mutations of the tyrosine kinase-directed ubiquitin ligase CBL cause myeloid leukemias, but the molecular determinants of the dominant leukemogenic activity of…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    The endocytic recycling regulatory protein EHD1 Is required for ocular lens development by Arya, Priyanka, Rainey, Mark A., Bhattacharyya, Sohinee, Mohapatra, Bhopal C., George, Manju, Kuracha, Murali R., Storck, Matthew D., Band, Vimla, Govindarajan, Venkatesh, Band, Hamid

    Published in Developmental biology (01-12-2015)
    “…The C-terminal Eps15 homology domain-containing (EHD) proteins play a key role in endocytic recycling, a fundamental cellular process that ensures the return…”
    Get full text
    Journal Article
  10. 10

    Cbl and Cbl-b ubiquitin ligases are essential for intestinal epithelial stem cell maintenance by Zutshi, Neha, Mohapatra, Bhopal C., Mondal, Pinaki, An, Wei, Goetz, Benjamin T., Wang, Shuo, Li, Sicong, Storck, Matthew D., Mercer, David F., Black, Adrian R., Thayer, Sarah P., Black, Jennifer D., Lin, Chi, Band, Vimla, Band, Hamid

    Published in iScience (21-06-2024)
    “…Receptor tyrosine kinases (RTKs) control stem cell maintenance vs. differentiation decisions. Casitas B-lineage lymphoma (CBL) family ubiquitin ligases are…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    CHIP/STUB1 Ubiquitin Ligase Functions as a Negative Regulator of ErbB2 by Promoting Its Early Post-Biosynthesis Degradation by Luan, Haitao, Bailey, Tameka A., Clubb, Robert J., Mohapatra, Bhopal C., Bhat, Aaqib M., Chakraborty, Sukanya, Islam, Namista, Mushtaq, Insha, Storck, Matthew D., Raja, Srikumar M., Band, Vimla, Band, Hamid

    Published in Cancers (04-08-2021)
    “…Overexpression of the epidermal growth factor receptor (EGFR) family member ErbB2 (HER2) drives oncogenesis in up to 25% of invasive breast cancers. ErbB2…”
    Get full text
    Journal Article
  14. 14

    Discrimination of tumor from normal tissues in a mouse model of breast cancer using CARS spectroscopy combined with PC‐DFA methodology by Huang, Xi, Yuan, Ye, Bielecki, Timothy A., Mohapatra, Bhopal C., Luan, Haitao, Silva‐Lopez, Edibaldo, West, William W., Band, Vimla, Lu, Yongfeng, Band, Hamid, Zhang, Tian C.

    Published in Journal of Raman spectroscopy (01-09-2017)
    “…Objective methodologies to discriminate tumor from normal tissue in biopsies and resection specimens are of great interest as complementary approaches to…”
    Get full text
    Journal Article
  15. 15

    VAV1-Cre mediated hematopoietic deletion of CBL and CBL-B leads to JMML-like aggressive early-neonatal myeloproliferative disease by An, Wei, Mohapatra, Bhopal C, Zutshi, Neha, Bielecki, Timothy A, Goez, Benjamin T, Luan, Haitao, Iseka, Fany, Mushtaq, Insha, Storck, Matthew D, Band, Vimla, Band, Hamid

    Published in Oncotarget (13-09-2016)
    “…CBL and CBL-B ubiquitin ligases play key roles in hematopoietic stem cell homeostasis and their aberrations are linked to leukemogenesis. Mutations of CBL,…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Fasudil, a clinically safe ROCK inhibitor, decreases disease burden in a Cbl/Cbl-b deficiency-driven murine model of myeloproliferative disorders by William, Basem M, An, Wei, Feng, Dan, Nadeau, Scott, Mohapatra, Bhopal C, Storck, Matthew A, Band, Vimla, Band, Hamid

    Published in Hematology (Luxembourg) (20-04-2016)
    “…Mutations in Cbl or Cbl-b gene occur in 10% of myeloproliferative disorder (MPD) patients and are associated with poor prognosis. Hematopoietic Cbl/Cbl-b…”
    Get more information
    Journal Article
  19. 19

    Loss of Cbl and Cbl-b ubiquitin ligases abrogates hematopoietic stem cell quiescence and sensitizes leukemic disease to chemotherapy by An, Wei, Nadeau, Scott A, Mohapatra, Bhopal C, Feng, Dan, Zutshi, Neha, Storck, Matthew D, Arya, Priyanka, Talmadge, James E, Meza, Jane L, Band, Vimla, Band, Hamid

    Published in Oncotarget (30-04-2015)
    “…Cbl and Cbl-b are tyrosine kinase-directed RING finger type ubiquitin ligases (E3s) that negatively regulate cellular activation pathways. E3…”
    Get full text
    Journal Article
  20. 20